Open Access

Iron deficiency and heart failure - evidence is piling up - what's next?

Event: Heart Failure 2021 Online Congress
Topic: Treatment
Session type: Satellite Symposium
Sponsored by Pharmacosmos
Date: 29 June 2021
Time: 11:40 - 12:25

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

7 presentations in this session

Introduction and welcome.

Speaker: Professor J. Cleland (Glasgow, GB)
Thumbnail

Functional and clinical outcomes with IV iron so far.

Speaker: Professor P. Van Der Meer (Groningen, NL)
Thumbnail

Recent evidence on ferric derisomaltose in heart failure.

Speaker: Doctor A. Ambrosy (San Francisco, US)
Thumbnail

Live Q&A.

Thumbnail

What's in the IV iron trial pipeline and what will it add?

Speaker: Professor P. Kalra (Portsmouth, GB)
Thumbnail

Live Q&A and Closing remarks.

Speaker: Professor J. Cleland (Glasgow, GB)
Thumbnail

5 speakers from this session

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
56 presentations
3 followers

Professor Peter Van Der Meer

University Medical Center Groningen, Groningen (Netherlands (The))
42 presentations
1 follower

Doctor Andrew Ambrosy

Kaiser Permanente Northern California, San Francisco (United States of America)
1 presentation
0 follower

Professor Paul Kalra

Queen Alexandra Hospital, Portsmouth (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
56 presentations
3 followers

Related content

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

ESC Guidelines 2021 - Heart Failure

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk